Lanean...
The pituitary TGFβ1 system as a novel target for the treatment of resistant prolactinomas
Prolactinomas are the most frequently observed pituitary adenomas and most of them respond well to conventional treatment with dopamine agonists. However, a subset of prolactinomas fails to respond to such therapies and is considered as dopamine agonist-resistant prolactinomas (DARPs). New therapeut...
Gorde:
| Argitaratua izan da: | J Endocrinol |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4760866/ https://ncbi.nlm.nih.gov/pubmed/26698564 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/JOE-15-0451 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|